OpenAlex
PricingAboutJobs
Log inGet started
Work

High-dose therapy for refractory multiple myeloma: improved prognosis with better supportive care and double transplants

HTML

Year: 1994
Type: article
Study design: Clinical Trial
Source: Blood
DOI: 10.1182/blood.v84.3.950.950
Authors: DH Vesole, B Barlogie, S Jagannath, B Cheson, G Tricot, R Alexanian, J Crowley
Institution: University of Arkansas for Medical Sciences
Language: English

Topic: Multiple Myeloma Research and Treatments
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Keywords: refractory multiple myeloma, high-dose therapy, melphalan, autologous bone marrow transplantation, peripheral blood stem cells, GM-CSF, total body irradiation, thiotepa, beta2-microglobulin, prognostic factors, event-free survival, overall survival, neutropenia, growth factor therapy, supportive care
SDG: Good health and well-being

Open Access status: closed

Funder: National Cancer Institute
Award: Growth Control in Multiple Myeloma
OpenAlex ID: W2418260674
FWCI: 10.01
Cites: 16
Cited by: 167
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms